Global Asthma and COPD Drugs Market Analysis, Trends And Opportunities 2020-2026
Summary -
A new market
study, titled “Global Asthma and COPD Drugs Products Market - Global Demand, Sales,
Consumption and Forecasts to 2020-2026“ has been featured on WiseGuyReports.
Global Asthma And COPD Drugs Market
Research Report—Forecast till 2025
Market
Analysis
The Global
Asthma and COPD Drugs Market are anticipated to exhibit a CAGR of 7.90% to
extend USD 43,444.72 Million during the review period. The market growth is
propelled by the rising prevalence and occurrence of asthma and COPD around the
globe. Asthma is a kind of inflammatory disorder that affects the lungs and
makes breathing uneasy. Asthma is considered as one of the common chronic
condition affecting many people across the world. COPD is an abbreviation of
chronic obstructive pulmonary disease in which occurs due to uncontrolled
asthma which becomes worse letter; an umbrella term used for a group of
respiratory diseases such as emphysema and chronic bronchitis.
Market
Segmentation
Global
Asthma and COPD Drugs Market have been categorized into disease, product, route
of administration, and distribution channel. The market, based on disease, has been
bifurcated into asthma and COPD.
On the
basis of the product segment, asthma and COPD drugs market has been divided
into long-term asthma control medications and quick-relief medications. The
long-term asthma control medications are again divided into combination drugs,
anticholinergics, inhaled corticosteroids, long-acting beta-agonists,
theophylline, and others. The combination drugs are subcategorized into
Seretide/Advair, Symbicort, Relvar/Breo Ellipta, Flutiform, Dulera, and Others.
Anticholinergics are further sub-categorized into Spiriva and others. The
Inhaled corticosteroids are further divided into Pulmicort, Flovent, Qvar, and
others.
The
quick-relief medications have been again segmented into short-acting
beta-agonists, oral & intravenous corticosteroids, ipratropium bromide
(Atrovent), and others. Short-acting beta-agonists have been again bifurcated
into Proair and Ventolin.
Global
asthma and COPD drugs market, based on the route of administration, has been
categorized into oral, inhaled, and others. Based on the distribution channels
category, global asthma and COPD drugs market has been segregated into retail
pharmacies, hospital pharmacies, and online pharmacies.
Regional
Analysis
Geographically,
the Global Asthma and COPD Drugs Market have been segmented into the Americas,
Europe, Asia-Pacific, and the Middle East & Africa.
The
Americas are likely to lead global asthma and COPD drugs market followed by
Europe. The regional market growth is been driven by the rising patient
population suffering from asthma and COPD, the increasing health expenditure
per person and the growing demand for advanced treatment options. The US contributes
the largest market share in the regional market.
The
European market for asthma and COPD drugs is evaluated to be the second-largest
market of the world during the review period owing to the increasing prevalence
of asthma and COPD. The increasing awareness of asthma and COPD in Europe is
expected to expand the growth of the regional market.
Asia-Pacific
is evaluated to be the rapid-growing market because of the rising awareness of
COPD and asthma and high prevalence of asthma and COPD in the region
Key Players
The
Prominent Players in the Global Asthma and COPD Drugs Market are
GlaxoSmithKline plc (UK), AstraZeneca (UK), Boehringer Ingelheim International
GmbH (Germany), and Chiesi Farmaceutici SpA (Italy).
We are
continuously tracking the impact of COVID-19 pandemic on various industries and
verticals within all domains. Our research reports include the same and help
you understand the drop and rise, owing to the impact of COVID-19 on the
industries. Also, we help you to identify the gap between the demand and supply
of your interested market. Moreover, the report helps you with the analysis,
amended government regulations and many other useful insights.
FOR MORE DETAILS:- https://www.wiseguyreports.com/reports/5415379-global-asthma-and-copd-drugs-market-research-report-forecast-till-2025
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH
TRENT
Ph: +162-825-80070
(US)
Ph: +44 2035002763
(UK)
Comments
Post a Comment